Cargando…

The Impact of the Timing of Health-Related Quality of Life Assessments on the Actual Results in Glioma Patients: A Randomized Prospective Study

Background: The aim of this study was to explore the impact of the timing of Health-Related Quality of Life (HRQoL) measurements in clinical care on the obtained HRQoL scores in glioma patients, and the association with feelings of anxiety or depression. Methods: Patients completed the European Orga...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peeters, Marthe C.M., Zwinkels, Hanneke, Koekkoek, Johan A.F., Vos, Maaike J., Dirven, Linda, Taphoorn, Martin J.B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465107/ https://www.ncbi.nlm.nih.gov/pubmed/32764261 http://dx.doi.org/10.3390/cancers12082172

Ejemplares similares

Prediagnostic presentations of glioma in primary care: a case–control study
por: Peeters, Marthe CM, et al.
Publicado: (2019)

Research Objectives, Statistical Analyses and Interpretation of Health-Related Quality of Life Data in Glioma Research: A Systematic Review
por: Coomans, Marijke B., et al.
Publicado: (2020)

Is the EORTC QLQ‐C30 emotional functioning scale appropriate as an initial screening measure to identify brain tumour patients who may possibly have a mood disorder?
por: Oort, Quirien, et al.
Publicado: (2022)

Retention rates of antiepileptic drugs in glioma patients: the most appropriate outcome
por: van der Meer, Pim B, et al.
Publicado: (2020)

Effectiveness of Antiseizure Medication Duotherapies in Patients With Glioma: A Multicenter Observational Cohort Study
por: van der Meer, Pim B., et al.
Publicado: (2022)

Effectiveness of Antiseizure Medication Triple Therapy in Patients With Glioma With Refractory Epilepsy: An Observational Cohort Study
por: van der Meer, Pim B., et al.
Publicado: (2023)

Advance care planning in glioblastoma patients: development of a disease-specific ACP program
por: Fritz, Lara, et al.
Publicado: (2019)

Impact of timing of antiseizure medication withdrawal on seizure recurrence in glioma patients: a retrospective observational study
por: van der Meer, Pim B., et al.
Publicado: (2023)

Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide
por: Koekkoek, Johan A. F., et al.
Publicado: (2015)

Health-related quality of life in high-grade glioma patients
por: Dirven, Linda, et al.
Publicado: (2014)

Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study
por: Koekkoek, Johan A F, et al.
Publicado: (2014)

First‐line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid
por: van der Meer, Pim B., et al.
Publicado: (2021)

First‐line levetiracetam versus enzyme‐inducing antiseizure medication in glioma patients with epilepsy
por: van der Meer, Pim B., et al.
Publicado: (2022)

Efficacy of antiepileptic drugs in glioma patients with epilepsy: a systematic review
por: de Bruin, Marjolein E, et al.
Publicado: (2021)

Effect of antiepileptic drugs in glioma patients on self-reported depression, anxiety, and cognitive complaints
por: van der Meer, Pim B., et al.
Publicado: (2021)

Management of epilepsy in brain tumor patients
por: van der Meer, Pim B., et al.
Publicado: (2022)

Evaluating the lack of impact of the e-health application Oncokompas on outcomes in incurably ill cancer patients
por: Dirven, Linda, et al.
Publicado: (2022)

Antiepileptic drug treatment in the end-of-life phase of glioma patients: a feasibility study
por: Koekkoek, Johan A. F., et al.
Publicado: (2015)

The effectiveness of antiepileptic drug treatment in glioma patients: lamotrigine versus lacosamide
por: van Opijnen, Mark P., et al.
Publicado: (2021)

Individual changes in neurocognitive functioning and health-related quality of life in patients with brain oligometastases treated with stereotactic radiotherapy
por: van der Meer, Pim B., et al.
Publicado: (2018)

Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study
por: Kerkhof, M., et al.
Publicado: (2019)

Depression and anxiety in glioma patients
por: van der Meer, Pim B, et al.
Publicado: (2023)

Advance Care Planning in Glioblastoma Patients
por: Fritz, Lara, et al.
Publicado: (2016)

Neurocognitive impairment and patient–proxy agreement on health-related quality of life evaluations in recurrent high-grade glioma patients
por: Caramanna, Ivan, et al.
Publicado: (2022)

Prescription preferences of antiepileptic drugs in brain tumor patients: An international survey among EANO members
por: van der Meer, Pim B, et al.
Publicado: (2021)

Importance of evaluating health-related quality of life issues in survivors of WHO grade II or III gliomas
por: Dirven, Linda
Publicado: (2022)

Health-related quality of life of cranial WHO grade I meningioma patients: are current questionnaires relevant?
por: Zamanipoor Najafabadi, Amir H., et al.
Publicado: (2017)

The impact of current treatment modalities on the outcomes of patients with melanoma brain metastases: A systematic review
por: van Opijnen, Mark P., et al.
Publicado: (2019)

eHealth cognitive rehabilitation for brain tumor patients: results of a randomized controlled trial
por: van der Linden, Sophie D., et al.
Publicado: (2021)

Incidence and determinants of thrombotic and bleeding complications in patients with glioblastoma
por: Kaptein, Fleur H. J., et al.
Publicado: (2022)

MRI phenotypes of glioblastomas early after treatment are suggestive of overall patient survival
por: Schmitz-Abecassis, Bárbara, et al.
Publicado: (2023)

Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period
por: Coomans, Marijke B, et al.
Publicado: (2022)

Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patients
por: Coomans, Marijke B, et al.
Publicado: (2020)

Actual Results of the Test
Publicado: (1914)

Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients
por: Dirven, Linda, et al.
Publicado: (2021)

Psychometric evaluation of an item bank for computerized adaptive testing of the EORTC QLQ-C30 cognitive functioning dimension in cancer patients
por: Dirven, Linda, et al.
Publicado: (2017)

Evaluation of the content coverage of questionnaires containing basic and instrumental activities of daily living (ADL) used in adult patients with brain tumors
por: Oort, Quirien, et al.
Publicado: (2019)

Does early resection of presumed low-grade glioma improve survival? A clinical perspective
por: Wijnenga, Maarten M. J., et al.
Publicado: (2017)

Clinical applicability of and changes in perfusion MR imaging in brain metastases after stereotactic radiotherapy
por: Kerkhof, M., et al.
Publicado: (2018)

Tannins: Prospectives and Actual Industrial Applications
por: Pizzi, Antonio
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d9j2eqopierbptdt0g26k2tcre